TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in TScan Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- +16 vs. Q1 2024
- Shares held
- 41.5M
- +7.20M (+21.0%) vs. Q1 2024
- Total value
- $242.6M
- −$29.6M (−10.9%) vs. Q1 2024
- New holders
- 32
- 19 more added
- Sold out
- 16
- 14 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 176 | $0 | 0.00% | −2,375−93.1% | Reduced |
| Price T Rowe Associates Inc | 12,301 | $0 | 0.00% | +12,301 | New |
| Atlas Capital Advisors LLC | 18 | $105 | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,329 | $8.00K | 0.00% | +1,329 | New |
| California State Teachers Retirement System | 2,782 | $16.3K | 0.00% | +2,782 | New |
| Royal Bank of Canada | 3,611 | $21.0K | 0.00% | +3,611 | New |
| Ameritas Investment Partners, Inc. | 3,762 | $22.0K | 0.00% | +3,762 | New |
| Legal & General Group Plc | 3,937 | $23.0K | 0.00% | +3,937 | New |
| Tower Research Capital LLC (TRC) | 4,224 | $24.7K | 0.00% | +4,224 | New |
| Citigroup Inc | 8,446 | $49.4K | 0.00% | −108,475−92.8% | Reduced |
| Waldron Private Wealth LLC | 10,000 | $58.5K | 0.00% | 00.0% | Unchanged |
| Aries Wealth Management | 10,000 | $58.5K | 0.02% | 00.0% | Unchanged |
| MetLife Investment Management | 10,199 | $59.7K | 0.00% | +10,199 | New |
| Jump Financial, LLC | 10,792 | $63.1K | 0.00% | +501+4.9% | Added |
| Privium Fund Management (UK) Ltd | 12,103 | $69.3K | 0.03% | −3,722−23.5% | Reduced |
| Dimensional Fund Advisors LP | 11,882 | $70.5K | 0.00% | +11,882 | New |
| Advisor Group Holdings, Inc. | 12,245 | $71.6K | 0.00% | +12,245 | New |
| UBS Group AG | 12,645 | $74.0K | 0.00% | +10,744+565.2% | Added |
| Barclays PLC | 13,164 | $77.0K | 0.00% | +13,164 | New |
| Marathon Trading Investment Management LLC | 13,600 | $79.6K | 0.02% | −37,400−73.3% | Reduced |
| Voya Investment Management LLC | 13,603 | $79.6K | 0.00% | +13,603 | New |
| Wells Fargo & Company | 13,886 | $81.2K | 0.00% | +13,580+4,437.9% | Added |
| Manufacturers Life Insurance Company, The | 15,383 | $90.0K | 0.00% | +15,383 | New |
| JPMorgan Chase & Co | 16,364 | $95.7K | 0.00% | −50,649−75.6% | Reduced |
| Man Group plc | 18,651 | $109.1K | 0.00% | −58,688−75.9% | Reduced |
| Squarepoint Ops LLC | 19,290 | $112.8K | 0.00% | +19,290 | New |
| New York State Common Retirement Fund | 20,093 | $117.5K | 0.00% | +20,093 | New |
| Deutsche Bank AG | 20,638 | $120.7K | 0.00% | +20,638 | New |
| Corebridge Financial, Inc. | 20,658 | $121.1K | 0.00% | +20,658 | New |
| Letko, Brosseau & Associates Inc | 20,700 | $121.1K | 0.00% | 00.0% | Unchanged |
| Pale Fire Capital SE | 21,573 | $126.2K | 0.01% | 00.0% | Unchanged |
| EntryPoint Capital, LLC | 21,899 | $128.1K | 0.06% | +21,899 | New |
| Cornercap Investment Counsel Inc | 22,940 | $134.2K | 0.02% | +22,940 | New |
| Millennium Management LLC | 27,889 | $163.2K | 0.00% | −364,226−92.9% | Reduced |
| Goldman Sachs Group Inc | 35,268 | $206.3K | 0.00% | −224,880−86.4% | Reduced |
| DC Investments Management, LLC | 35,563 | $208.0K | 0.18% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 38,300 | $224.1K | 0.01% | −25,000−39.5% | Reduced |
| Bank of America Corp | 43,782 | $256.1K | 0.00% | +13,603+45.1% | Added |
| Rhumbline Advisers | 46,867 | $274.2K | 0.00% | +46,867 | New |
| American Century Companies Inc | 47,481 | $277.8K | 0.00% | +15,596+48.9% | Added |
| Laurion Capital Management LP | 60,400 | $353.3K | 0.01% | −302,084−83.3% | Reduced |
| Nuveen Asset Management, LLC | 69,962 | $409.3K | 0.00% | +69,962 | New |
| Brown Brothers Harriman & Co | 76,024 | $444.7K | 0.00% | +76,024 | New |
| Qube Research & Technologies Ltd | 78,385 | $458.6K | 0.00% | −65,151−45.4% | Reduced |
| Renaissance Technologies LLC | 80,000 | $468.0K | 0.00% | +33,000+70.2% | Added |
| Wellington Management Group LLP | 90,941 | $532.0K | 0.00% | +90,941 | New |
| NewEdge Wealth, LLC | 91,463 | $535.1K | 0.01% | 00.0% | Unchanged |
| Troluce Capital Advisors LLC | 92,832 | $543.1K | 0.11% | +92,832 | New |
| Stifel Financial Corp | 95,400 | $558.1K | 0.00% | −6,000−5.9% | Reduced |
| Northern Trust Corp | 97,512 | $570.4K | 0.00% | +20,552+26.7% | Added |
| Jane Street Group, LLC | 99,036 | $579.4K | 0.00% | −54,097−35.3% | Reduced |
| Walleye Capital LLC | 107,665 | $629.8K | 0.01% | +55,187+105.2% | Added |
| Charles Schwab Investment Management Inc | 112,941 | $660.7K | 0.00% | +90,837+411.0% | Added |
| Bank of New York Mellon Corp | 116,658 | $682.4K | 0.00% | +116,658 | New |
| Bank of Montreal | 120,454 | $749.2K | 0.00% | +120,454 | New |
| Alpine Global Management, LLC | 137,490 | $804.3K | 0.14% | +137,490 | New |
| Citadel Advisors LLC | 157,963 | $924.1K | 0.00% | +146,531+1,281.8% | Added |
| Woodline Partners LP | 163,492 | $956.4K | 0.01% | +163,492 | New |
| Tocqueville Asset Management L.P. | 209,830 | $1.23M | 0.02% | −2,370−1.1% | Reduced |
| Morgan Stanley | 241,672 | $1.41M | 0.00% | +17,778+7.9% | Added |
| Standard Life Aberdeen plc | 292,144 | $1.71M | 0.00% | +92,144+46.1% | Added |
| Marshall Wace, LLP | 307,487 | $1.80M | 0.00% | +116,316+60.8% | Added |
| Paradigm Biocapital Advisors LP | 353,886 | $2.07M | 0.08% | +353,886 | New |
| Invesco Ltd. | 499,874 | $2.92M | 0.00% | +11,459+2.3% | Added |
| State Street Corp | 608,085 | $3.56M | 0.00% | +473,085+350.4% | Added |
| DC Funds, LP | 630,000 | $3.69M | 61.20% | 00.0% | Unchanged |
| LMR Partners LLP | 665,529 | $3.89M | 0.08% | +665,529 | New |
| StemPoint Capital LP | 845,069 | $4.94M | 1.45% | +845,069 | New |
| Geode Capital Management, LLC | 900,499 | $5.27M | 0.00% | +486,720+117.6% | Added |
| Great Point Partners LLC | 940,831 | $5.50M | 1.05% | +940,831 | New |
| Simplify Asset Management Inc. | 1,046,916 | $6.12M | 0.54% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $6.30M | 0.32% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,504 | $7.29M | 1.50% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 2,087,139 | $12.2M | 7.92% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,133,613 | $12.5M | 0.00% | +325,461+18.0% | Added |
| Baker Bros. Advisors LP | 2,784,792 | $16.3M | 0.21% | 00.0% | Unchanged |
| BVF Inc | 2,989,474 | $17.5M | 0.49% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,400,000 | $25.7M | 0.05% | +500,000+12.8% | Added |
| BlackRock Inc. | 4,462,352 | $26.1M | 0.00% | +2,763,139+162.6% | Added |
| EcoR1 Capital, LLC | 5,000,000 | $29.3M | 0.90% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 5,224,600 | $30.6M | 11.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −297,902−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −44,308−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −41,942−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −37,747−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −35,661−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −34,789−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −34,578−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −24,446−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −19,736−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −14,200−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −10,061−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,618−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |